Promethera

Promethera is a biopharmaceutical company that develops and commercializes novel cell-based therapies for the treatment of chronic liver diseases.

Business Model:

Revenue: $11M

Employees: 51-200

Detailed Promethera Information

Geographic Data

Promethera headquarters map

Address: Rue Granbonpre, 11

City: Mont-Saint-Guibert

State: walloon brabant

Zip: B-1435

Country: BE

Financial Info

Stage:

series d

Raised Last:

$8M

Raised Total:

$145M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Promethera is a biopharmaceutical company that develops and commercializes novel cell-based therapies for the treatment of chronic liver diseases.

Contact Phone:
+13210394300

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2018 Convertible Note 2 $11.5M Shibuya Kogyo
Shinsei Corporate Investment
Shibuya Kogyo
Shinsei Corporate Investment
12/2019 Series D 2 $8.4M Pegasus Tech Ventures
Sony Innovation Fund
Pegasus Tech Ventures
Sony Innovation Fund
10/2016 Series C 7 $10.9M Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
3/2012 Series B $0 Shire
Mitsui Global Investment
Boehringer Ingelheim Venture Fund
Shire
Mitsui Global Investment
Boehringer Ingelheim Venture Fund
11/2014 Series C $0 Boehringer Ingelheim
Shire
SFPI-FPIM
Boehringer Ingelheim
Shire
SFPI-FPIM
6/2019 Series D 2 $48.1M ITOCHU Technology Ventures
Sansei Capital Investment
ITOCHU Technology Ventures
Sansei Capital Investment
2/2010 Series A 4 $7.3M Vesalius Biocapital Partners
S.R.I.W.
Limburgse Reconversie Maatschappij
EQT life science
11/2014 Series C $31.4M Vesalius Biocapital
Boehringer Ingelheim Venture Fund
Shire
Mitsui Global Investment
SFPI-FPIM
SMS Investments
5/2019 Series D $44.4M Itochu Corp
Shinsei Capital Partners
Medipal Holdings Corp
Mirae Asset Capital
Korea Investment Partners
Mitsui & Co. Global Investment Ltd
10/2016 Series C $11M Vesalius Biocapital
SRIW
Fund+
Boehringer Ingelheim Venture Fund
4/2018 Debt $11.4M
12/2019 Series D $8.3M Sony Innovation Fund
Pegasus Tech Ventures
Medipal Holdings Corporation
12/2019 Series D 2 $8.4M Pegasus Tech Ventures
Sony Innovation Fund
Pegasus Tech Ventures
Sony Innovation Fund
4/2018 Convertible Note 2 $11.5M Shibuya Kogyo
Shinsei Corporate Investment
Shibuya Kogyo
Shinsei Corporate Investment
10/2016 Series C 7 $10.9M Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
11/2014 Series C 3 $31.6M
3/2012 Series B 3 $31.4M
Announced Date Name Price
4/2018 Baliopharm

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research